Clinical Trial Update: Botulinum Toxin Type A (BT-A) in Hemiplegic Shoulder Pain Versus Steroid [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing Botulinum toxin type A to a corticosteroid for hemiplegic shoulder pain in stroke patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemiparesis
• Hemiplegic Shoulder Pain
• Stroke

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)
• Corticosteroid (corticosteroid)

Snippet

Sponsor: The Foundation Institute San Raffaele G. Giglio of Cefalù | Conditions: Stroke, Hemiparesis | Phase 2 | Status: UNKNOWN